PYCR1 and non-small cell lung carcinoma: Our findings reveal that PYCR1 is significantly upregulated in patient-derived NSCLC tissues compared with their matched lung normal tissues, and its expression correlates with the activation of oncogenic pathways and in vivo tumorigenicity.